Background After hepatectomy, over-and under-resuscitations induce cardiopulmonary complications and acute kidney injury, respectively, leading to significant perioperative morbidity and mortality. Unlike serum chemistries or urine output, serum brain natriuretic peptide (BNP) levels have been shown to accurately reflect current intravascular fluid balance without influence from alterations of hormonal axes. Based on these data, this study was designed to measure the impact of a serum BNP-guided hepatobiliary fluid protocol on the incidence of posthepatectomy cardiopulmonary/renal complications. Methods Hepatectomy patients registered in a single-institution American College of Surgeons-National Surgical Quality Improvement Program database between 2011 and 2016 were examined in real time for the development of cardiopulmonary/ renal complications and divided into pre-(2011-2013) and postimplementation (2014-2016) of a BNP-guided hepatobiliary fluid protocol groups. In the postimplementation group, maintenance fluids were tapered on a set protocol. Bolus fluids, diuresis, and micro-adjustments in fluid rate were guided by daily BNP values. Results Four hundred sixty patients underwent hepatectomy in the study period with 251 patients in the pre-and 209 patients in the postprotocol implementation groups. Cardiopulmonary/renal complication rates were 4.0% in the preprotocol group and reduced to 0.9% after initiation of the BNP-guided hepatobiliary fluid protocol (p = 0.04). Conclusions Despite low event rates, these data suggest that goal-directed postoperative fluid therapy with the combination of a hepatobiliary fluid protocol and serum BNP-guided volume management is superior to traditional chemistry and bedside volume assessment and can reduce posthepatectomy cardiopulmonary and renal complications.
Introduction
Maintenance of euvolemia after hepatectomy is essential to preserve effective circulatory blood volume and organ perfusion. Hypo-or hypervolemia resulting in fluid imbalance in the postoperative period can lead to prolonged hospital stay, increased morbidity, and development of cardiopulmonary and/or renal complications. 1 Traditional non-invasive modalities of assessing volume status, such as urine output and serum blood urea nitrogen (BUN) and creatinine (CRN) levels, can be inaccurate in the settings of baseline renal insufficiency, alterations of the hormonal axis, and fluid third-spacing. 2 Change in body weight over time, which is one of the most accurate measures of volume status, is often inadequate because of the lack of dependable measurements. 3 Although invasive measures of cardiac output and intravascular fluid status can provide more precise data, a monitored intensive care unit is required but not practical for the routine, awake floor patient. Therefore, a better measure is needed to help guide fluid therapy in the postoperative setting after liver resection. Serum brain natriuretic peptide (BNP) is a 32-amino-acid protein produced in the cardiac atria and ventricles in response to chamber dilation from volume expansion and pressure overload. 2, 4 After release into the circulation, BNP promotes diuresis, natriuresis, reduction of preload, and afterload by binding to the guanylate cyclase receptors on endothelial cells. 4 When measured in surgical patients, BNP levels can provide prognostic and predictive values for the development of postoperative complications.
The preoperative utilization of BNP for cardiac risk assessment in high-risk patients has been endorsed by the European Society of Cardiology and European Society of Anesthesiology. 5, 6 Meta-analyses have demonstrated that an elevated preoperative BNP level is predictive of serious cardiovascular complications and when measured postoperatively provides additional risk stratification for mortality or non-fatal myocardial infarction after noncardiac surgery. 5, 7 BNP levels have also been shown to parallel changes in fluid balance and resuscitation. Friese et al. examined BNP levels in the trauma intensive care unit and found that serum levels increased with resuscitation. 8 In the postoperative setting, Berri et al. demonstrated that serum BNP provided better intervascular volume assessment than did changes in the BUN/CRN ratio, particularly during the early phase of recovery from pancreatectomy. 2 These data suggest that BNP levels can be used to guide fluid resuscitation and management in the postoperative period; however, no studies specific to liver surgery have validated these findings.
Of all the fields of surgery, liver surgery demands the most precision in intravascular volume management. Liver resections are associated with dramatic intravascular fluid shifts as patients are maintained in low-central-venouspressure states during parenchymal transection and are aggressively resuscitated after completion. Subsequent liver function depends on maintaining a slight hypovolemic to euvolemic state, despite the confounders of fluid shifts and frequent use of epidural analgesia. These dynamic forces uniquely place the patient at risk for hypervolemic pulmonary, cardiac, and hepatic complications and hypovolemic renal complications. In order to address the need for more accurate volume assessment in liver surgery patients, this study was designed to measure the impact of a BNP-guided hepatobiliary fluid protocol on posthepatectomy cardiopulmonary and renal complications.
Methods

Patients and Data Collection
Permission from The University of Texas MD Anderson Cancer Center institutional review board was obtained prior to data collection and analysis. Inclusion of institutional American College of Surgeons (ACS)-National Surgical Quality Improvement Program (NSQIP) data was compliant with the NSQIP data use agreement. The institution subscribes to the Bessentials model^in ACS-NSQIP with random collection of 14% of all surgical cases. Non-risk adjusted outcome data were obtained from the institutional ACS-NSQIP database from January 2011 to December 2016 to identify all patients that underwent hepatectomy.
Pre-, intra-, and postoperative variables in the dataset were collected by surgical clinical reviewers trained by NSQIP in medical record analysis. Overall and severe complication rates were recorded for the entire cohort. Severe complications were defined as the development of the following NSQIP-specified occurrences: return to the operating room, organ space infection, dehiscence, ventilator dependence or failure to wean > 48 h, reintubation, acute renal insufficiency or failure, cardiac arrest or myocardial infarction, stroke or coma, venous thromboembolism, sepsis or septic shock, or pneumonia.
Postoperative serum BNP, BUN, and CRN levels and fluid balance (intake and output) were collected by retrospective chart review by the author for postoperative days 0-5. BNP levels were measured using the Alere Triage® BNP test with the Beckman Coulter® access immunoassay system. This system employs a mouse monoclonal anti-human antibody, and testing was performed in our institutional central laboratory. Hospital cost, including overhead, for this test was $12.20.
Two group outcomes were assessed and compared: pre-(2011-2013) and postimplementation (2014-2016) of the BNP-guided hepatobiliary fluid protocol.
To determine the ability of the protocol to prevent both hypovolemic and hypervolemic complications, the cardiopulmonary/renal (CP/R) complications were evaluated using data from the NSQIP dataset as a composite measure of myocardial infarction, intubation > 48 h, need for reintubation, or development of acute kidney injury (CRN > 2 mg/dL).
BNP-Guided Hepatobiliary Fluid Protocol
In the first 8 h postoperatively, patients were resuscitated with D5NS + 16 mmol potassium phosphate (KPhos) at 100-125 mL/h (16 mmol of KPhos contains 24 meq of potassium). During the next 16 h (hours 9-24), when the patient was experiencing peak third-spacing, the normotonic fluid rate was decreased to 42-75 mL/h determined by early postoperative BNP level and urine output. On the afternoon of postoperative day 1, the fluid composition was changed to D5 1/2NS + 16 mmol KPhos at a rate of 42-75 mL/h based on daily BNP level and urine output.
If BNP was < 100 pg/mL or urine output decreased to < 50 mL/2 h, a 250-500 mL 5% albumin bolus was administered and the maintenance fluid rate was kept constant.
If BNP was 100-200 pg/mL, no bolus was given and the maintenance intravenous (IV) fluid rate was minimized. If patients had an elevated BNP > 200 pg/mL, the maintenance IV fluid rate was minimized or stopped and dieresis is considered. Patients with early, extreme, or persistent BNP elevations were urgently evaluated for diastolic dysfunction or heart failure. Once a patient was able to tolerate > 600 mL of oral intake per day, maintenance fluids were stopped according to enhanced recovery guidelines (Fig. 1) . Fig. 1 The Evans, Pisters, and Lee BNP-guided hepatobiliary fluid protocol algorithms. Oliguria is defined as urine output < 50 mL/2 h. KPhos, potassium phosphate; BNP, brain natriuretic peptide; MIVF, maintenance intravenous fluid
Statistical Analysis
The two groups' outcomes were assessed and compared: pre-(2011-2013) and postimplementation (2014-2016) of the B N P -g u i d e d h e p a t o b i l i a r y f l u i d p r o t o c o l . T h e preimplementation and postimplementation groups were compared for the incidence of comorbidities and case types. Likewise, complication, readmission, and mortality rates were compared. In the 2014-2016 group, fluid balance (intake and output) and serum BNP, BUN, and CRN levels were examined for postoperative days 0 to 5. Fluid balance was calculated by the difference between intake and output for a given postoperative day. Serum BNP level was evaluated as an individual value. BUN and CRN were evaluated as a composite ratio expressed as BUN divided by CRN. Box plots were created to evaluate the distribution of fluid balance (intake minus output), serum BNP level, and BUN/CRN ratio for each postoperative day.
Data analysis was performed utilizing the IBM Statistical Package for the Social Sciences 22.0 software for Windows (SPSS, Inc. Chicago, IL). All tests were two-sided, and a P value of < 0.05 was considered statistically significant. Chisquare analyses were used to evaluate associations between categorical variables, and Student's t test was used to evaluate differences in means between the two groups of normally distributed continuous variables.
Results
Patient Characteristics
Four hundred sixty NSQIP-registered patients underwent hepatectomy during the study period, with 251 patients in the preand 209 patients in the post-BNP-guided hepatobiliary fluid protocol implementation groups. Table 1 provides the descriptive characteristics of the patient population. Fifty-two percent of patients were male, the median age was 56 years, the median BMI was 27 g/m 2 , and 85% of patients were white. Diabetes (insulin-or non-insulindependent) was present in 11%, 8% were smokers, 0.4% had COPD, and 37% had hypertension. Ninety-one percent of patients had an American Society of Anesthesiologists (ASA) score of 3, and the median MELD score was 7. Open surgery was performed in 97% of cases; 61% underwent a partial hepatectomy, 17% a trisegmentectomy, 15% a right hepatectomy, and 4% a left hepatectomy. The median operative time was 250 min, and the median length of hospital stay was 6 days. Fifty-seven percent of patients had had a prior abdominal operation, and 56% had received systemic chemotherapy < 90 days before the operation.
The postoperative overall complication rate was 13%, and the severe complication rate was 10%. Transfusions were administered to 11% (n = 49) of patients, with a median of 2 units of blood. No patients died within 90 days of surgery.
Between the pre-and postintervention groups, there were no differences in demographic or comorbidity distributions (Table 1) . Regarding case magnitude, there was a trend toward parenchymal-sparing hepatectomy, but this also correlated with an increase in case length (Table 1) .
Within the postintervention cohort, 75% of patients had BNP values either > 200 pg/mL or < 100 pg/mL. In these patients, BNP values were actively used to assist fluid management decision-making (Fig. 2) . The actionable range for volume adjustment is broader for BNP (25-75%, 34 to 184 pg/mL) when compared to BUN (25-75%, 9 to 17 pg/ mL) or CRN (25-75%, 0.6 to 1.0 pg/mL), where the ranges were narrower.
Diuresis was administered to 12% of patients who were clinically asymptomatic with BNP values > 200 pg/mL. Fluid bolus was given to 5% of patients with a normal urine output and BNP value < 100 pg/mL.
Cardiopulmonary/Renal Complications
Overall, the CP/R complication rate was 3%. In the preimplementation group, the CP/R complication rate was 4.0% (n = 10), while only 0.9% (n = 2) of postprotocol implementation patients experienced CP/R complications (P = 0.04).
Within the composite complication metric consisting of myocardial infarction, need for intubation (either reintubation or prolonged postoperative intubation), and acute kidney injury, none of the patients developed a myocardial infarction; nine required intubation, which was secondary to volume overload; and three patients developed acute kidney injury. Figure 3 shows CP/R events over the study time period. Table 2 provides descriptive characteristics of the patients who developed CP/R complications. Within this subgroup, 58% was male, and the median age was 58 years. All patients who developed CP/R complications were white. None of the patients was a smoker or had COPD, but 8% had insulindependent diabetes, and half had hypertension. Ninety-two percent of patients with these complications had an ASA status of 3 with 50% undergoing a partial hepatectomy, 25% a right hepatectomy, 17% a trisegmentectomy, and 8% a left hepatectomy. All cases were open with a median operative time of only 188 min.
Patients who developed a CP/R complication had a lower median preoperative albumin level (3.9 versus 4.2, P = 0.007) and a higher postoperative transfusion rate (50 versus 10%, P < 0.001). The development of these complications was significant as these patients had a longer average length of hospital stay than did patients who did not have these complications (6 versus 12 days, P < 0.001).
Fluid Volume Assessments
Box plots were created to examine the relationships between fluid balance (intake-output), BNP level, and BUN/CRN ratio for postoperative days 0-5 in the 209 patients in the postprotocol intervention group (Fig. 4 ). There were no significant differences between median BNP values over the postoperative period (P > 0.05), indicating that the hepatobiliary fluid protocol compensated for physiologic volume shifts to maintain fairly consistent intravascular volume status.
In Fig. 5 , cumulative fluid balance for the postprotocol implementation patients is shown in comparison to the standard fluid intake seen after colectomy, demonstrating that a low overall cumulative fluid balance was achieved using the BNP-guided hepatobiliary fluid protocol. 
Discussion
Balanced fluid resuscitation to achieve euvolemia is of paramount importance in patients undergoing liver surgery. The development of either volume overload of the intravascular and interstitial fluid compartment or hypovolemic underresuscitation can result in increased morbidity, prolonged hospital stay, and even mortality. To date, highly accurate postoperative measures of volume status that account for physiologic and iatrogenic fluid shifts are lacking. In an effort to enhance Bprecision liver surgery,^this study proposed the combination of a regimented hepatobiliary fluid protocol with BNP-based modifications to improve patient outcomes. 9 Analysis of the outcome data in this study demonstrates that utilization of a BNP-guided hepatobiliary fluid protocol can help the clinical team to maintain patient euvolemia. By simultaneously limiting unnecessary fluid administration and guiding appropriate fluid supplementation, the protocol reduced both cardiopulmonary and renal complications.
There are several additional positive attributes of the protocol. First, the protocol is non-invasive. Invasive methods of measuring volume status are not practical in the routine, awake hepatectomy patient. BNP level can provide a non-invasive means of determining intravascular volume status that is more immediate, accurate, and actionable than BUN and CRN levels or ratio. Second, BNP testing is inexpensive. At our institution, the test has a cost of only $12.20 per sample. This cost is easily justified against a return on investment of 3 out of every 100 patients avoiding cardiopulmonary and/or renal complications, which in our study resulted in a doubling of length of stay. In addition, cost savings are further accentuated by the protocol's ability to refine and limit the indications for relatively expensive albumin fluid boluses. Third, BNP is constitutively produced, not stored, and has a short half-life of 21 min, thereby allowing for real-time and repeated assessments of serum levels. Fourth, BNP is degraded by natriuretic peptide C receptors and neutral endopeptidases, maintaining its reliability as a marker of intravascular volume status even in situations of decreased glomerular filtration rates. 10 Fifth, early, extreme, and/or persistent elevations of BNP can signal the potential of underlying cardiac dysfunction that may have catastrophic consequences if left untreated. Previous studies, performed in postoperative oncologic but not hepatectomy patients, have demonstrated that variations in BNP levels parallel intravascular fluid shifts. 2, 11 To our knowledge, this is the first study to corroborate these findings in the hepatectomy patient population, where intravascular fluid shifts can be particularly prevalent and impactful on outcomes. Likewise, this is the first study to report the utilization of BNP levels to make specific decisions on fluid adjustments using a regimented protocol.
The maintenance hepatobiliary fluid choice used in this protocol deserves additional discussion. The maintenance fluid portion of this regimen, including the composition of the fluids and the strategy for tapering sodium concentration and rate, has been used in hepatopancreatobiliary surgery at our institution for over 15 years. The Binvention^of the regimen is attributed to Douglas Evans, MD; Peter Pisters, MD; and Jeffrey E. Lee, MD. The rationale for the protocol is that the patient is maintained on an initially high rate of normotonic saline during the first 24 postoperative hours, competing against cortisol-induced third-spacing when its effect is at its maximum. Giving one half normal saline during this critical phase, a common practice throughout most of gastrointestinal surgeries, results in donation of at least half the delivered volume to the interstitial tissues, with multiple adverse sequelae, including poor renal perfusion, almost universally resulting in early oliguria and the need for fluid boluses. Matching the rate and tonicity of fluid to the patient's most intravascularly dry period, the hepatobiliary fluid protocol reduces bolus demand to less than one per patient on average. Although it is generally felt that excessive saline can be harmful to postoperative liver function, we find that this is not seen in our liver patients when the isotonic saline is limited to the first 24 h, including in patients with cirrhosis.
12 -14 The benefits of this practice are considerable, and the hepatic-specific risk is negligible to non-existent.
After this acute 24-h period, the maintenance fluids are transitioned to a D51/2NS solution, limiting the sodium load and avoiding hyperchloremic metabolic acidosis and its associated coagulopathy. The addition of 16 mmol KPhos was chosen as it provides 24 meq potassium and a continuous supplementation of phosphate. In hepatectomy patients, the phosphate infusion is critical to provide substrate for ATP production in the rapidly regenerating liver, avoiding potentially morbid depletion of phosphate stores and muscular failure. We find that the more robust continuous supplementation of both potassium and phosphorus is valuable for nonliver patients, as well, as it significantly reduces ileus and clinician and nursing staff workloads with significantly lower requirements for electrolyte boluses to maintain normal laboratory levels. In the absence of preexisting renal insufficiency or acute kidney injury, early mild elevations in serum potassium and/or phosphorus that occur on the regimen are harmless and rapidly return to normal without intervention as the IVF rate is tapered on the protocol. In this study cohort, transient mild hyperphosphatemia and/or hyperkalemia did develop in 15% of patients. All cases of hyperkalemia resolved without additional intervention and were tolerated without any adverse cardiac events or arrhythmias.
During the two time periods, 2011-2013 and 2014-2016, there were no major changes in the operative techniques utilized at this institution. The two-surgeon technique with saline-linked cautery and ultrasonic dissection has been the standard strategy for parenchymal transaction, and routine intraoperative air leak test was utilized for major hepatectomies to reduce the rate of postoperative biliary fistula. 15, 16 Despite a heavily pretreated population with frequent preexisting anemia, red blood cell transfusion rates were low, and no other blood product types were given. 17 There was a trend toward more parenchymal-sparing hepatectomy, which could be interpreted as a covariate for reduced complications. However, while these procedures reduced the risk of postoperative hepatic insufficiency by preserving remnant liver volume, they paradoxically require more frequent and prolonged inflow occlusion and may not necessarily be less risky in the early postoperative period. To reinforce this point, patients in the postimplementation cohort had significantly longer operative times, which likely put them at increased risk for cardiopulmonary and/or renal complications. Our enhanced recovery protocol was initiated in January of 2011.
Although euvolemia was achieved postoperatively using the postoperative fluid protocol, it is important to note that this program was coupled with intraoperative goal-directed therapy. Throughout the study period, previously reported uniform intraoperative goal-directed fluid and blood product replacement protocols were utilized. 17 For over a decade, we have not used central venous catheters; instead, optimal intraoperative resuscitation was accomplished by effective crosstable communication with anesthesia during the entire case, judicious use of fluids and vasopressors, and non-invasive stroke volume variation monitoring using an arterial line.
There are several limitations of this study. Because institutional NSQIP data were used, there are more granular cardiopulmonary outcomes that were not captured by the database, such as arrhythmias, pulmonary effusions, and pulmonary edema. However, had these issues arisen and progressed, their more serious associated events, including reintubation, would have been captured. Another potential critique is that we did not routinely obtain preoperative BNP levels. Although these would have provided a baseline and they may have some prognostic value, in the absence of a history of congestive heart failure or new cardiac signs and symptoms, preoperative BNP has not been shown to aid in the management of noncardiac surgery patients. 1, 5 It could also be argued that our findings can be attributed to generally increased vigilance. Although it is difficult to refute this possibility, during these time periods, the level of the trainee (complex general surgical oncology fellow and hepatopancreatobiliary fellow) and advanced practice provider caring for these patients did not change, and all other order sets remained the same. Finally, because of the low event rate, only a limited number of prognostic and predictive risk factors for the development of CP/R complications were identified.
Conclusions
Our data and analysis indicate that intraoperative goaldirected therapy coupled with our programmatic hepatobiliary fluid protocol with serum BNP-guided modifications is a simple, ubiquitously available, evidence-based, and cost-saving practice that facilitates increased precision in the care of liver surgery patients, reduces resources needed for IV boluses, and leads to better outcomes.
